These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The effects of botulinum toxin in spasticity and headaches: a common key? Sandrini G Funct Neurol; 2008; 23(2):61. PubMed ID: 18671904 [No Abstract] [Full Text] [Related]
6. The current use of botulinum toxin. Mahant N; Clouston PD; Lorentz IT J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658 [TBL] [Abstract][Full Text] [Related]
7. Dystonia and headaches: clinical features and response to botulinum toxin therapy. Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690 [No Abstract] [Full Text] [Related]
8. New therapeutic indications for botulinum toxins. Cordivari C; Misra VP; Catania S; Lees AJ Mov Disord; 2004 Mar; 19 Suppl 8():S157-61. PubMed ID: 15027069 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxins: pharmacology and its current therapeutic evidence for use. Panicker JN; Muthane UB Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921 [TBL] [Abstract][Full Text] [Related]
10. Local treatment of dystonia and spasticity with injections of botulinum-A toxin. Calne S Axone; 1993 Jun; 14(4):85-8. PubMed ID: 8274387 [TBL] [Abstract][Full Text] [Related]
12. The use of botulinum toxin in physical medicine and rehabilitation. Cuevas-Trisán RL; Cruz-Jiménez M Bol Asoc Med P R; 2006; 98(1):42-55. PubMed ID: 19610549 [TBL] [Abstract][Full Text] [Related]
13. Emerging therapeutic applications of botulinum toxin. Thant ZS; Tan EK Med Sci Monit; 2003 Feb; 9(2):RA40-8. PubMed ID: 12601305 [TBL] [Abstract][Full Text] [Related]
14. Dose standardization of botulinum toxin. Van den Bergh PY; Lison DF Adv Neurol; 1998; 78():231-5. PubMed ID: 9750920 [No Abstract] [Full Text] [Related]
15. Botulinum toxin in movement disorders. Papapetropoulos S; Singer C Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263 [TBL] [Abstract][Full Text] [Related]
16. Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gait. O'Brien CF Adv Neurol; 2001; 87():265-9. PubMed ID: 11347231 [No Abstract] [Full Text] [Related]
17. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Naumann M; So Y; Argoff CE; Childers MK; Dykstra DD; Gronseth GS; Jabbari B; Kaufmann HC; Schurch B; Silberstein SD; Simpson DM; Neurology; 2008 May; 70(19):1707-14. PubMed ID: 18458231 [TBL] [Abstract][Full Text] [Related]
18. Application of botulinum toxin to clinical therapy: advances and cautions. Levy NS; Lowenthal DT Am J Ther; 2012 Jul; 19(4):281-6. PubMed ID: 22481607 [TBL] [Abstract][Full Text] [Related]
19. [Indications and management of botulinum toxin]. Singer C Rev Neurol; 1999 Jul 16-31; 29(2):157-62. PubMed ID: 10528331 [TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin-B and the management of hyperhidrosis. Baumann LS; Halem ML Clin Dermatol; 2004; 22(1):60-5. PubMed ID: 15158547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]